Xenon Pharmaceuticals Inc (XENE) is a publicly traded Healthcare sector company. As of September 17, 2026, XENE trades at $42.12 with a market cap of $5.50B and a P/E ratio of -13.17. XENE moved +1.14% today. Year to date, XENE is +28.91%; over the trailing twelve months it is +56.27%. Its 52-week range spans $26.74 to $72.66. Analyst consensus is strong buy with an average price target of $78.00. Rallies surfaces XENE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for XENE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $42.12 |
| Market Cap | $5.50B |
| P/E Ratio | -13.17 |
| EPS | $-4.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $72.66 |
| 52-Week Low | $26.74 |
| Volume | 706.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.50M |
| Net Income | $-345.91M |
| Gross Margin | 0.00% |
12 analysts cover XENE: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $78.00.